Introduction {#Sec1}
============

Blood loss is unavoidable after total knee arthroplasty (TKA). In recent years, a growing number of effective agents and new techniques for avoiding allogeneic blood transfusions (ABT) have been reported because ABTs may lead to serious complications \[[@CR10]\]. However, the safest and most efficient method has not been identified.

As a measure to reduce the blood transfusions and blood loss associated with TKA, preoperative autologous blood donations have been used since 1990. However, the procedure is associated with the problems of troublesome administrative tasks, high costs, contraindications in patients with anemia, and the limited storage period. Some studies reported that an excessive volume of blood was stored \[[@CR4], [@CR5], [@CR7], [@CR9], [@CR11], [@CR23]\].

As a strategy for reducing blood loss, drain clamping has been combined with intravenous or intra-articular administration of tranexamic acid (TNA) and intra-articular injection of diluted-epinephrine (DEP) since approximately 1995, and the preventive effect on blood loss is well documented \[[@CR3], [@CR8], [@CR25]\].

The objective of the present study was to compare the rate of avoidance of ABTs combined with the use of TNA and DEP in preoperative autologous blood donations and develop a protocol for safe ABTs in TKA by combining TNA and DEP, based on the results of the comparison. The proposed hypothesis was that a means of using TNA plus DEP would increase the proportion of patients who would not require ABTs rather than preoperative autologous blood donations.

Materials and methods {#Sec2}
=====================

This study was a non-randomized, retrospective study that included 133 knees undergoing unilateral primary TKA from 2004 through 2007. All surgeries were performed by a single surgeon (SH). General anesthesia and continuous femoral nerve blocks were used. The implant used in all patients was the Scorpio NRG^®^ posterior-stabilized type (Stryker Howmedica Osteonics, Allendale, NJ). In all patients, the patella was replaced, and all components were fixed with cement. Surgery was performed under tourniquet control. After midline skin incision, a medial parapatellar approach was utilized. Depending on the study period, three measures were implemented to reduce blood loss and blood transfusions. Exclusion criteria were known allergies to tranexamic acid, ASA-IV physical status or higher, severe ischemia and/or heart valve disease, history of thromboembolic episodes, known coagulopathy, and renal dysfunction (serum creatinine concentration, \>1.5 mg/dL).The autologous blood transfusion group (group A, *n* = 51)

During the early study period, autologous blood was collected on preoperative day 4 or earlier (mean, 2.2 units). Indications for preoperative autologous blood donations were based on the Standards for Preoperative Autologous Blood Donations (2007) developed by the Japanese Society of Autologous Blood Transfusions. Patients had to have a blood hemoglobin (Hb) level of 11.0 g/dL or more or a hematocrit level of 33% or more. No age limit was established. Oral iron preparations were administered at a daily dose of 200 mg for 1 week before initial blood collection. When the collection of 4 or more units of blood took 1 week or longer, 24,000 units of recombinant human erythropoietin (ESPO^®^, epoetinum alfa, Kyowa Kirin Co. Ltd., Tokyo, Japan) was administered subcutaneously. On postoperative day 1, all patients received autologous blood transfusions. After surgery, a drain was inserted, and no specific postoperative blood loss was prevented.The intravenous TNA plus intra-articular DEP group (group B, *n* = 42)

Twenty minutes before surgery, 1,000 mg of TNA (Transamin 10%^®^, Daiichi-Sankyo Co. Ltd., Tokyo, Japan) was administered intravenously. After wound closure, 50 mL of epinephrine diluted to 1:200,000 was injected intra-articularly without drain insertion.The intravenous TNA plus intra-articular DEP plus drain-clamping group (group C, *n* = 40)

As in the case of group B, TNA was administered intravenously. When the wound was closed, however, an intra-articular drain was inserted, and 50 mL of epinephrine diluted to 1:200,000 was injected intra-articularly. The suction drain was clamped for the first 3 h and then unclamped in group C. The drain was removed 48 h later in groups A and C. As part of the postoperative care for the three groups, continuous passive movement was started on postoperative day 3, and standing and full-weight-bearing walking were allowed.

Bleeding-related outcome measures included changes in Hb, drained blood loss (group A and C), total postoperative blood loss, proportion of patients requiring no allogenic blood transfusions, and complications related to the prevention of blood loss. Hb levels were measured on the day before surgery and postoperative days 1, 4, and 7. A formula proposed by Nadler et al. \[[@CR20]\] and Sehat et al. \[[@CR24]\] was used to calculate the total postoperative blood loss. The loss of Hb was then estimated according to the following formula:$$\documentclass[12pt]{minimal}
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To investigate the influence on the development of postoperative deep vein thrombosis (DVT) and pulmonary embolisms (PE), contrast-enhanced computed tomography (CT) was performed in patients with a [d]{.smallcaps}-dimer level of 20 μg/mL or more on postoperative days 1, 4, 7, and 14 and those with clinical symptoms suggestive of DVT. Images were read by two radiologists. Patients with a diagnosis of DVT or PE and those with persistently elevated [d]{.smallcaps}-dimer levels received continuous heparin infusion and oral warfarin therapy. Oral warfarin was continued for 3 months. Oral therapy was controlled to achieve a target INR of 2--3. On postoperative day 14, patients were also examined for postoperative skin disorders (skin necrosis, skin loss, and superficial infections).

Statistical analysis {#Sec3}
--------------------

ANOVA and an unpaired *t*-test were used to analyze parametric data, whereas a chi-square test among the three groups was used for non-parametric data. When a significant difference was found, groups were compared using the Bonferroni method. A *P*-value of 0.05 or less was considered a significant difference.

Results {#Sec4}
=======

Among the three groups, there were no significant differences in patient characteristics of gender, age, underlying disease, body weight, and height (Table [1](#Tab1){ref-type="table"}). At any point in time (preoperative day and postoperative day 1, 4, or 7), there were no significant differences among the three groups (Table [2](#Tab2){ref-type="table"}, postoperative Hb). The postoperative drained blood loss (Table [2](#Tab2){ref-type="table"}) was 535 ± 212 mL and 328 ± 109 mL in groups A and C, respectively, indicating a significant reduction in group C (*P* = 0.00001). As shown in Fig. [1](#Fig1){ref-type="fig"}, the total postoperative blood loss in groups B and C was significantly less than that in group A (*P* = 0.0009). In Table [2](#Tab2){ref-type="table"}, the proportion of patients requiring no ABTs was 94% (48/51) in group A, 93% (39/42) in group B, and 95% (38/40) in group C, with no significant differences among the three groups. Finally, in the development of DVT and PE (Table [3](#Tab3){ref-type="table"}), there were no significant differences among the three groups. All cases of PE were asymptomatic. As for skin conditions (Table [3](#Tab3){ref-type="table"}), there were no significant differences among the three groups for complications in the wound area.Table 1Patient characteristicsGroup AGroup BGroup C*P* value(*n* = 51)(*n* = 42)(*n* = 40)Gender (male/female)4/476/365/35n.s.Age (year)70 ± 1068 ± 965 ± 12n.s.Disease (RA/OA)16/3520/2218/22n.s.Body weight (kg)55 ± 1055 ± 1156 ± 9.5n.s.Height (cm)149 ± 10150 ± 8.7151 ± 7.9n.s.Values are expressed as mean ± SD. There was no significant difference in every category*RA* rheumatoid arthritis, *OA* osteoarthritisTable 2Hemoglobin (Hb) level concentrations before and after operation and drained blood loss, transfusion requirementsGroup AGroup BGroup C*P* valuePreoperative Hb (g/dl)12.0 ± 1.012.2 ± 1.612.4 ± 1.4n.s.Postoperative Hb (g/dl) Day 19.4 ± 1.510.1 ± 1.310.0 ± 1.2n.s. Day 49.4 ± 1.39.3 ± 1.28.9 ± 1.5n.s. Day 79.6 ± 1.49.5 ± 1.39.1 ± 1.6n.s.Fall in Hb (g/dl) Preop--day 12.3 ± 1.42.4 ± 0.9 Day 1--day 41.0 ± 1.21.1 ± 1.1 Drained blood loss (ml)535 ± 212328 ± 1090.00001Allogeneic transfusion needs Number of patients332n.s. Avoidance rate (%)949395Values are expressed as mean ± SDFig. 1Total postoperative blood lossTable 3Postoperative complicationsGroup AGroup BGroup C*P* valueNumber of DVT1079n.s.Number of PE112n.s.Number of skin trouble (necrosis, loss, infection)211n.s.Values are expressed as mean ± SD or number*DVT* deep venous thrombosis, *PE* pulmonary embolism

Discussion {#Sec5}
==========

The most important finding of the present study was that the rate of avoidance of ABT in TNA plus the combination of DEP was similar to that of preoperative autologous blood transfusions. Considering the several problems of preoperative autologous blood donations \[[@CR4], [@CR5], [@CR7], [@CR9], [@CR11], [@CR23]\], DEP plus TNA can be a more effective method of handling postoperative blood loss in avoiding ABT.

Since the reports by Benoni et al. \[[@CR3]\], many groups have reported the usefulness of TNA in TKA \[[@CR1], [@CR6], [@CR19], [@CR21]\]. Cid et al. \[[@CR8]\] performed a meta-analysis of the use of TNA in reducing blood loss in TKA and reported that the use of TNA significantly reduced the number of patients requiring blood transfusions and the volume of each blood transfusion. Although complications due to thrombosis caused by fibrinolytic inhibition have been a concern, there have been no reports of such complications \[[@CR25]\]. Similarly, there were no significant differences in the incidence of DVT or PE among the three groups.

The effect of drain clamping plus DEP after TKA has been controversial. Anderson et al. \[[@CR2]\] and Gasparini et al. \[[@CR12]\] reported that intra-articular injections of DEP decreased blood loss after TKA. On the other hand, Malone et al. \[[@CR16]\] reported that intra-articular injections of DEP were not effective. Some reports suggest that long periods of DEP plus drain clamping increased the development of skin lesions \[[@CR12], [@CR16]\]. In the current study, the hemostatic effect of intra-articular injection of DEP alone and the incidence of complications were not compared. However, skin disorders did not occur more frequently in group B in which no drain was inserted. Actually, swelling of the thigh and lower leg during the first two weeks after surgery was more severe in group B (no drain inserted) than in group C. Thus, measures to reduce blood are now implemented as in group C.

Some studies have recently stressed the importance of establishing an ABT protocol as a way to reduce postoperative blood loss and blood transfusions \[[@CR14], [@CR15], [@CR17]\]. In other studies, it has been reported that the preoperative Hb level is a risk factor for postoperative blood transfusions \[[@CR13], [@CR14], [@CR18], [@CR22]\]. Predicting the lowest postoperative Hb level from the preoperative Hb level, Jeffery et al. \[[@CR15]\] developed and implemented an algorithm for ABTs. The authors reported a 14% reduction in the rate of blood transfusions. Analysis of the change in Hb from baseline in patients showed that the Hb levels in groups B and C decreased by 2.3 and 2.4 g/dL, respectively, on postoperative day 1 and further decreased by 1.0 and 1.1 g/dL, respectively, on postoperative day 4. Thus, there were overall decreases of 3.3 and 3.5 g/dL in groups B and C, respectively (Table [2](#Tab2){ref-type="table"}). The guidelines from the blood transfusion committee in the hospital indicate that the Hb level at which ABTs are indicated is 7--8 g/dL in patients without cardiovascular and other systemic symptoms who undergo elective orthopedic surgery. Given that an Hb level of 7 g/dL or less is an indication of ABTs, concomitant use of intravenous TNA and postoperative intra-articular injections of DEP potentially eliminates the need for blood transfusions in patients with a preoperative Hb level of 10.5 g/dL or more. An algorithm was developed: when the Hb level on postoperative day 1 decreases to 7--8 g/dL, ABTs may be necessary depending on the patient's condition. When the Hb level on postoperative day 1 ranges from 8 to 9 g/dL, decisions are made on the basis of hematologic test results on postoperative day 4 (Fig. [2](#Fig2){ref-type="fig"}). Treatment is now provided according to this algorithm without preoperative autologous blood donations.Fig. 2Our recommended allogeneic blood transfusion protocol in primary TKAs

The present study had several limitations. This was a retrospective study. Although there were no differences in patient characteristics among the three groups, selection bias was not completely excluded in this study. The synergistic effect of administration of TNA or intra-articular DEP was not investigated. Both the administration of TNA and intra-articular DEP reduced postoperative blood loss after tourniquet release, and further studies (RCTs) are needed to determine dosage and administration. The clinical relevance of this study was that the combination of TNA and DEP might supplant autologous blood transfusions in order to reduce ABTs in unilateral primary TKA.

Conclusion {#Sec6}
==========

The results of the current study demonstrated that the TNA plus DEP combination exerted a comparable effect with preoperative autologous blood transfusions in avoiding ABTs in unilateral primary TKA. Considering the several problems of preoperative autologous blood donation, the use of TNA and DEP is recommended to prevent blood loss. In addition, allogeneic blood transfusions may be avoided for patients with Hb values ≥10.5 by using this method, and the need for preoperative autologous blood donations can be decreased.
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